Rahasson R. Ager, Ph.D.

2009 Biological Sciences - Ph.D. University of California, Irvine, Irvine, CA 
Molecular Biology, Neuroscience Biology
"Rahasson Ager"
Mean distance: 26716.5


Sign in to add mentor
Andrea J. Tenner grad student 2009 UC Irvine
 (The contribution of the complement system in the development of Alzheimer's disease pathology and cognitive dysfunction.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Baglietto-Vargas D, Chen Y, Suh D, et al. (2015) Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice. Journal of Neurochemistry
Ager RR, Davis JL, Agazaryan A, et al. (2015) Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss. Hippocampus. 25: 813-26
Dunn HC, Ager RR, Baglietto-Vargas D, et al. (2015) Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model. Journal of Alzheimer's Disease : Jad. 43: 893-903
Martinez-Coria H, Yeung ST, Ager RR, et al. (2015) Corrigendum to "Repeated cognitive stimulation alleviates memory impairments in an Alzheimer's disease mouse model" [Brain Res. Bull. 117 (2015) 10-15] DOI 10.1016/j.brainresbull.2015.07.001 Brain Research Bulletin. 119: 104
Yeung ST, Martinez-Coria H, Ager RR, et al. (2015) Repeated cognitive stimulation alleviates memory impairments in an Alzheimer's disease mouse model Brain Research Bulletin. 117: 10-15
Walls KC, Ager RR, Vasilevko V, et al. (2014) p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice. Neuroscience Letters. 575: 96-100
Ager RR, Fonseca MI, Chu SH, et al. (2010) Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease. Journal of Neurochemistry. 113: 389-401
Woodruff TM, Ager RR, Tenner AJ, et al. (2010) The role of the complement system and the activation fragment C5a in the central nervous system. Neuromolecular Medicine. 12: 179-92
Fonseca MI, Ager RR, Chu SH, et al. (2009) Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. Journal of Immunology (Baltimore, Md. : 1950). 183: 1375-83
Klos A, Tenner AJ, Johswich KO, et al. (2009) The role of the anaphylatoxins in health and disease. Molecular Immunology. 46: 2753-66
See more...